Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04991792
Other study ID # 510646
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 23, 2021
Est. completion date July 2024

Study information

Verified date May 2023
Source HiPP GmbH & Co. Vertrieb KG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A multi-centre, randomized, parallel-group, double-blind, controlled, exploratory clinical trial is conducted to assess the positive effect of feeding a formula containing synbiotics (pre- and probiotics) on the composition of the gut microbiota in caesarean section (CS) born healthy term infants within the first 6 months of life.


Description:

Since caesarean section (CS)-born infants show dysbiotic microbial colonization during the first weeks of life, exclusive breastfeeding is the feeding mode of choice for these infants. However, since CS births are often associated with breast-feeding difficulties, it is of importance to feed an microbiota-supportive infant formula. This study is designed to investigate whether an infant formula supplemented with synbiotics positively affects the microbial composition, gastrointestinal characteristics and the proper function of the immune system in CS-born infants, compared to feeding a standard infant formula without synbiotics in either CS- and vaginal-born infants during the first 6 months of life. The growth of the infants as well as tolerance, infectious diseases and allergies will also be assessed. In order to investigate the effect of different birth modes and feeding conditions on the microbiota, the study population will include healthy term infants, born either by CS or by VD, additional groups receive human milk or formula with prebiotics only. Additionally, if the parents agree, their infant will be followed up until 24 months of age with a special focus on the prevention of infections and allergies.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 486
Est. completion date July 2024
Est. primary completion date November 29, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 4 Days to 6 Days
Eligibility Inclusion Criteria: - Healthy term infants - Female or male gender - Gestational age =37 weeks, <42 weeks - Singleton, born by caesarean section or vaginally born - Birth weight between =2500g and =4200g with a regular weight gain without any signs of developmental delays or growth disorders according to investigator opinion - Uncomplicated early course of neonatal period - Age at enrolment: 5 +/-1 days of life - Infants whose parent(s)/ legal authorized representatives (LAR(s)) have reached the legal age of majority in Bulgaria - Infants whose parent(s)/ LAR(s) are capable of and willing to comply with the protocol and have signed the informed consent form in accordance with legal requirements - At least one of the legal representatives is affiliated to a health security/insurance or equally - Infants whose parent(s)/ LAR(s) are willing to comply with the feeding regimen during the intervention period. Infant's parent(s)/ LAR(s) will decide which feeding regimen will be used (infant formula or breast milk) - Parents/ LARs who agree to not use any sort of other formula than provided during the study Exclusion Criteria: - Intensive care prior to or at Baseline Visit - UV-treatment of jaundice and clinical significant jaundice prior to Baseline Visit (according to investigator opinion) - Known immune deficiency - Serious acquired or congenital diseases, chromosomal anomalies (if known) - Serious pre-natal and/or serious post-natal disease before enrolment (per investigator's medical diagnosis) - Infants or mothers under antibiotic treatment before Baseline Visit (only for vaginally born and breastfed infants) or at Baseline Visit (all groups) - Infants requiring infant formula intake other than those specified in the protocol (formula for special medical purposes (FSMP), formula with hydrolyzed protein (allergy risk) - Infant's supplementation or formula intake, which contains probiotics, prebiotics, dietary fibres or synbiotics before and during study - Feeding difficulties or formula intolerance according to investigator's opinion - Currently participating or having participated in another clinical trial since birth - Reason to presume that the infant's parent(s)/LAR(s) are unable to meet the study plan requirements, such as drug/alcohol abuse, psychological or linguistic incapability, chronic or mental diseases - Infants born to mothers with medical conditions that require prescription medication (coagulation abnormalities, if acetylsalicylic acid was not stopped at 35 weeks GA according to guidelines, mothers treated with Methyldopa, ACE inhibitors, breastfeeding mothers treated with L-thyroxine, diabetic mothers, epileptic mothers) - Any smoking, drug or alcohol intake by the mother during the last two trimesters of pregnancy - Mother's weight gain >18 kg during pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intervention Group 1: Infant Formula with synbiotics
Infants will receive infant formula during the first 6 months of life
Intervention Group 2: Infant Formula with prebiotics
Infants will receive infant formula during the first 6 months of life
Control Group 1 and 2: Infant Formula without synbiotics
Infants will receive infant formula during the first 6 months of life

Locations

Country Name City State
Bulgaria University multiprofile hospital for active treatment "Dr. Georgi Stranski" EAD Pleven

Sponsors (2)

Lead Sponsor Collaborator
HiPP GmbH & Co. Vertrieb KG University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski EAD, Pleven, Bulgaria

Country where clinical trial is conducted

Bulgaria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment whether an infant formula containing synbiotics positively affects the composition of the gut microbiota in CS-born infants compared to a standard formula (without synbiotics) or breast-feeding within the first 6 months of life 6 months duration
See also
  Status Clinical Trial Phase
Completed NCT02151825 - Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects N/A
Completed NCT01545219 - A Study of a Prebiotic, a Probiotic and a Synbiotic Upon the Gut Microbiota and Immune Response of Healthy Volunteers N/A
Active, not recruiting NCT04435548 - Westlake Gut Microbiome Study
Enrolling by invitation NCT05057039 - The Study of Gut Microbiota in Hypertensive Patients
Not yet recruiting NCT05039060 - Modified MAC Diet and Gut Microbiota in CRC Patients N/A
Completed NCT03746158 - Interindividual Variation in Excretion of Curcumin N/A
Active, not recruiting NCT03266055 - Effects of Blueberry on Gut Microbiota and Metabolic Syndrome N/A
Completed NCT04960878 - The Effect of Synbiotics on the Upper Respiratory Tract Infection N/A
Active, not recruiting NCT05607745 - Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study N/A
Recruiting NCT04120051 - The SIMBA Project - The Effect of a Prebiotic Supplement on Glucose Metabolism and Gut Microbiota in Obese Adults N/A
Not yet recruiting NCT05481866 - Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum N/A
Completed NCT03293693 - Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects N/A
Completed NCT02207140 - Effect of Multi-species Probiotic HOWARU® Restore, on Gut Microbiota of Elderly Phase 0
Recruiting NCT04203459 - The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation
Active, not recruiting NCT03259685 - Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome N/A
Recruiting NCT06157346 - Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
Completed NCT03203044 - Impact of Soylent Consumption on Human Microbiome Composition N/A
Recruiting NCT05975541 - Susceptibility to Infectious Diseases in Obesity
Active, not recruiting NCT05457439 - Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the Environment N/A
Recruiting NCT05008120 - Gut Microbiota in Major Depressive Disorders With and Without Rapid Eye Movement Behavior Disorder